American Vanguard Corporation
AVDBasic MaterialsNASDAQAgricultural Inputs · Last scanned Oct 24, 2026
Scan Results
Daily timeframeAmerican Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets synthetic, biological, and biorational products for agricultural, commercial, and consumer uses in the. The company carries a $30.4M market cap, placing it firmly in the micro-cap category. The company synthesizes and formulates chemicals and ferments and extracts microbial products for crops, turf, ornamental plants, and human and animal health protection, such as insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms.
Market Cap
$30.4M
Beta
1.50
P/E (TTM)
—
P/E (Fwd)
2.64
EPS (TTM)
$-1.86
EPS (Fwd)
$0.39
ROE
-26.5%
ROA
0.7%
Cash
$43.9M
Total Debt
$284.1M
Free CF
-$24.1M
52W Change
-80.8%
Annual Financials
Cash vs Debt
Where AVD stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, AVD finished 56.15% below its 150-day moving average ($2.44) and 64.21% below its 200-day moving average ($2.99). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is AVD overbought or oversold?
At the October 20, 2026 close, AVD's RSI(14) was 13.5, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, AVD has $43.9M in cash with $284.1M in obligations. The ability to service this debt comfortably depends on continued operational cash generation. The company is burning cash, with free cash flow at -$24.1M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. ROE of -26.5% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 0.7% is on the lower side, which is common in asset-heavy industries. Revenue has pulled back from $609.6M (2022) to $515.1M (2025), a 16% decline worth watching.
The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing AVD.